Related Experiment Video
Updated: Feb 21, 2026

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells
Published on: May 13, 2022
Oxidative Stress and Cancer: The Role of Nrf2
Soraya Sajadimajd1, Mozafar Khazaei1
1Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Abstract:
Oxidative stress due to imbalance between ROS production and detoxification plays a pivotal role in determining cell fate. In response to the excessive ROS, apoptotic signaling pathway is activated to promote normal cell death. However, through deregulation of biomolecules, high amount of ROS promotes carcinogenesis in cells with defective signaling factors. In this line, NRF2 appears to be as a master regulator, which protects cells from oxidative and electrophilic stress. Nrf2 is an intracellular transcription factor that regulates the expression of a number of genes to encode anti-oxidative enzymes, detoxifying factors, anti-apoptotic proteins and drug transporters. Under normal condition, Nrf2 is commonly degraded in cytoplasm by interaction with Keap1 inhibitor as an adaptor for ubiquitination factors. However, high amount of ROS activates tyrosine kinases to dissociate Nrf2: Keap1 complex, nuclear import of Nrf2 and coordinated activation of cytoprotective gene expression. Nevertheless, deregulation of Nrf2 and/or Keap1 due to mutation and activated upstream oncogenes is associated with nuclear accumulation and constitutive activation of Nrf2 to protect cells from apoptosis and induce proliferation, metastasis and chemoresistance. Owning to the interplay of ROS and Nrf2 signaling pathways with carcinogenesis, Nrf2 modulation seems to be important in the personalization of cancer therapy.
Insights
Oxidative stress impacts cell fate, with excessive reactive oxygen species (ROS) promoting cancer. The NRF2 pathway regulates cellular defense, but its deregulation can lead to cancer progression and treatment resistance.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Oxidative stress, an imbalance in reactive oxygen species (ROS) production and detoxification, critically influences cell fate.
- Excessive ROS can trigger apoptosis for normal cell death, but also promote carcinogenesis by deregulating biomolecules in cells with faulty signaling.
- The Nuclear factor erythroid 2-related factor 2 (NRF2) is a master regulator protecting cells against oxidative and electrophilic stress.
Purpose of the Study:
- To elucidate the role of the NRF2 signaling pathway in cellular response to oxidative stress and its implications in carcinogenesis.
- To understand the regulatory mechanisms of NRF2 activation and its link to cancer development, including proliferation, metastasis, and chemoresistance.
- To explore the potential of NRF2 modulation in personalized cancer therapy.
Main Methods:
- Review of existing literature on oxidative stress, ROS, NRF2, Keap1, and their roles in cellular processes and cancer.
- Analysis of the molecular mechanisms governing NRF2 activation, including its interaction with Keap1 and the impact of ROS.
- Examination of the consequences of NRF2/Keap1 deregulation in cancer, such as mutations and oncogene activation.
Main Results:
- NRF2 controls the expression of genes encoding antioxidant enzymes, detoxifying factors, anti-apoptotic proteins, and drug transporters.
- Under oxidative stress, ROS triggers the dissociation of the NRF2:Keap1 complex, leading to NRF2 nuclear import and activation of cytoprotective genes.
- Deregulation of NRF2/Keap1 is linked to constitutive NRF2 activation, promoting cancer cell survival, proliferation, metastasis, and chemoresistance.
Conclusions:
- The interplay between ROS and NRF2 signaling is crucial in the development and progression of cancer.
- Aberrant NRF2 activation confers survival advantages to cancer cells, contributing to therapeutic challenges.
- Targeting the NRF2 pathway holds promise for developing novel, personalized cancer treatment strategies.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Psychoneuroimmunology: Diabetes and Cancer
Regulation of the Unfolded Protein Response

